Dr. Muna A. Alnimri, MD

Dr. Alnimri practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Alnimri's NPI, 1407993264, was assigned on January 31, 2007. Dr. Alnimri graduated from University of Jordan Faculty of Medicine in 1987. Dr. Alnimri holds California license A104037.

Dr. Alnimri's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Alnimri's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alnimri practices. Vendor and product names are available with a free account.

Nephrology is Dr. Alnimri's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Alnimri is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Alnimri's licenses on file in 3 states: California, Oregon and New York.

Dmand AI lists chronic kidney disease among the conditions Dr. Alnimri treats.

CMS data shows 748 Medicare services from Dr. Alnimri across 7 procedure codes in 2024, for 225 Medicare patients. Medicare paid $49,581 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 225 Medicare patients who saw Dr. Alnimri in 2024. The largest group is under 65, with 144 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 57% are also on Medicaid. Their average risk score is 5.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alnimri's median patient age at 55, with 42% women.

In 2024, Dr. Alnimri wrote 1,904 Medicare Part D claims for 242 patients. 87% of them were for generic drugs. CMS names the drug for 1,673 of them, across 40 drugs with 11 or more claims each, at $122,106 in total drug cost. In 2023, CMS named 1,721 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Alnimri for performance year 2024, reported as part of a group. Dr. Alnimri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alnimri as offering telehealth.

Dmand AI links 12 papers to Dr. Alnimri, published from 2018 to 2023. The most frequent topics are Kidney Transplantation, Immunosuppressive Agents and Antilymphocyte Serum. Dr. Alnimri has published most often in Transplant Proc. Dr. Alnimri's most frequent co-authors are Mark R. Laftavi, MD, Ling-Xin Chen, MD and Alan Koff.

Dmand AI lists 1 award for Dr. Alnimri, most recently CMS Stage 1 EHR in 2013.

Dr. Alnimri graduated from University of Jordan Faculty of Medicine in 1987.

Dr. Alnimri is in network with 8 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.